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Abstract
Background: Studies have shown that abdominal girth and vertebral column length have high predictive value for
spinal spread after administering a dose of plain bupivacaine. we designed a study to identify the specific
correlations between abdominal girth, vertebral column length and a 0.5 % dosage of plain bupivacaine, which
should provide a minimum upper block level (T12) and a suitable upper block level (T10) for lower limb surgeries.
Methods: A suitable dose of 0.5 % plain bupivacaine was administered intrathecally between the L3 and L4
vertebrae for lower limb surgeries. If the upper cephalad spread of the patient by loss of pinprick discrimination
was T12 or T10, the patient was enrolled in this study. Five patient variables and intrathecal plain bupivacaine dose
were recorded. Linear regression and multiple regression analyses were performed.
Results: Totals of 111 patients and 121 patients who lost pinprick discrimination at T12 and T10, respectively, were
analyzed in this study. Linear regression analysis showed that only abdominal girth and plain bupivacaine dose
were strongly correlated (r =−0.827 for T12, r = −0.806 for T10; both p < 0.0001). Multiple linear regression analysis
showed that both abdominal girth and vertebral column length were the key determinants of plain bupivacaine
dose (both p < 0.0001). R2 was 0.874 and 0.860 for the loss of pinprick discrimination at T12 and T10, respectively.
Conclusions: Our data indicated that vertebral column length and abdominal girth were strongly correlated with
the dosage of intrathecal plain bupivacaine for the loss of pinprick discrimination at T12 and T10. The two regression
equations were YT12 = 3.547 + 0.045X1-0.044X2 and YT10 = 3.848 + 0.047X1- 0.046X2 (Y, 0.5 % plain bupivacaine
volume; X1, vertebral column length;and X2, abdominal girth), which can accurately predict the minimum and
suitable intrathecal bupivacaine dose for lower limb surgery to a great extent, separately.
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Background
Plain bupivacaine spinal anesthesia is a conventional
technique [1–5]. However, the spread of intrathecal plain
bupivacaine is highly unpredictable [6]. Previous studies
have proven that at least 25 factors could affect the
spread of spinal anesthesia [7–9]. Lumbosacral cerebro-
spinal fluid volume was found to be the primary deter-
minant that affect spinal cephalad spread [10],
lumbosacral cerebrospinal fluid pressure was also an im-
portant factor that affects spinal cephalad spread [11],
but those informations had little practical value because
they were inconvenient to obtain. Clinically, patient’s
age, height, weight, and body mass index (BMI), have
commonly been considered when determining the dose
of bupivacaine. However, previous studies have reported
that these variables were only weakly to moderately cor-
related with and had little predictive value for the spread
of spinal anesthesia [1, 3, 12–14].
Our previous study showed that abdominal girth and
vertebral column length were highly predictive of the
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spread of spinal anesthesia after a given dose of plain bupi-
vacaine [15]. However, the results did not suggest a specific
dose of bupivacaine for an individual. T12 spinal spread
level was nearly the minimum block level for eliminating
tourniquet pain and T10 spinal spread levels could provide
satisfactory analgesia with almost no hemodynamic effects
for lower limb surgery. Plain 0.5 % bupivacaine has
frequently been used for spinal anesthesia [1, 3, 13, 16].
Therefore, we designed a prospective, observational study
to identify the specific correlations between abdominal
girth, vertebral column length and a 0.5 % dosage of plain
bupivacaine, which should provide a minimum upper




This study was approved by the Ethical Committee of the
Second Affiliated Hospital of Jiaxing University (Ethical
Committee number CZJE 201311; Chairperson Professor
Li-qin Jiang) on 11 February 2013. All patients provided
prior written informed consent.
Patients
A total of 692 patients were enrolled in this study from
February 2013 to March 2014, and the following inclusion
criteria were applied: ASA physical status I and II, 19–60
years old, and were scheduled for lower limb fractures sur-
gery, hip arthroplasty, knee arthroplasty, knee arthroscopy,
great saphenous vein surgery and so on. Patients with
contraindications for spinal anesthesia, diabetes, rheuma-
toid arthritis, spinal canal stenosis, a history of spinal
anesthesia or spinal surgery, pregnant patients and pa-
tients with language disorders were excluded.
Intervention
All patients fasted for 8–10 h before surgery. After the
patients entered the operating room, intravenous access
was established, and Ringer’s lactate 10 ml/kg was pre-
loaded before anesthesia. Noninvasive arterial pressure
was recorded every 5 min; electrocardiography and pulse
oximetry were continuously monitored for all patients.
The patients were placed in supine position, and at the
level of the umbilicus, the abdominal girth was mea-
sured at the end of expiration. Before spinal anesthesia
was administered, the patient was placed in the right lat-
eral decubitus position, with spinal column flexion. Dur-
ing spinal anesthesia, the L3-4 interspace was confirmed
by ultrasound imaging, a 25-gauge Quincke spinal needle
was inserted, and a midline approach was adopted, with
the orifice pointing toward the cephalad. We set T10
spinal block level as the target level, and a dose of 0.5 %
plain bupivacaine that the anesthesiologist deemed suit-
able was injected intrathecally with room temperature at a
speed of approximately 2 ml in 10 s when free flow of the
cerebrospinal fluid was obtained. After the procedure, the
patient was placed supine position immediately. The
spinal anesthesia spread was assessed using an 18-gauge
sharp needle every 10 min in both midclavicular lines till
60 min after the intrathecal injection. At each level, three
pin touches were employed for the loss of pinprick dis-
crimination. If the ultimate spinal anesthesia level of loss
of pinprick discrimination in both midclavicular lines was
T12 or T10 in 60 min after the intrathecal injection, the
patient was picked out to analyze in our study, and the
vertebral column length was measured from the C7 verte-
bra to the sacral hiatus, with the patient placed supine on
the operation table. The sacral hiatus and C7 vertebra
were both confirmed by radiographic imaging.
Two anesthetists participated in the study. All anesthesia
procedures and patient management were performed by
the same anesthetist, and assessment of the spinal
anesthesia spreads were performed by another anesthetist,
who was unaware of the bupivacaine dose used in each pa-
tient. Patients,age, height, weight, vertebral column length
abdominal girth and 0.5 % bupivacaine dose were recorded.
Statistical analysis
The sample size was determined as described in refer-
ence 15. If the anticipated effect size was 0.15, the de-
sired statistical power level was 0.8, the predictors were
5, and the minimum required sample size was 91, with a
probability level of 0.05. SPSS software (SPSS Inc., Chi-
cago, IL, USA), version 19.0, was used to analyze the
data. Linear regression analysis was performed to deter-
mine the correlations between the spinal anesthesia -in-
duced loss of pinprick discrimination at T12 or T10 and
patients, age, weight, height, abdominal girth, and verte-
bral column length. Multiple regression analysis was per-
formed to test the combined linear contributions of
patients,age, height, weight, vertebral column length and
abdominal girth to the bupivacaine dose for T10 or T12
loss of pinprick discrimination. During multiple regres-
sion analysis, stepwise selection was performed, and the
predictors were removed from the analysis if they were
not significantly correlated with the dependent variable.
R2 was the coefficient of determination. A p value < 0.05
was considered to be statistically significant.
Results
Of 692 potential participants, 45 failed to meet the
inclusion criteria,391 patients had spread levels other
than T10 or T12 (the maximum block level was T4, the
minimal block level was L2), and 24 were excluded for
other reasons. The remaining 232 patients (111 patients
with loss of pinprick discrimination at T12, 121 patients
with loss of pinprick discrimination at T10) were analysed
in this study (Fig. 1). There were no significant differences
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in the variables between those patients with loss of pin-
prick discrimination at T12 and at T10 (p > 0.05) (Table 1).
Linear regression analysis showed that there were sig-
nificant univariate correlations between height, weight,
abdominal girth, and vertebral column length and the
0.5 % plain bupivacaine volume for loss of pinprick dis-
crimination at T12 or T10 (all p < 0.0324). However, only
abdominal girth and 0.5 % plain bupivacaine volume were
strongly correlated (r = −0.827 for T12, r = −0.806 for T10;
p < 0.000) (Table 2; Figs. 2 and 3).
Multiple linear regression analysis showed that abdom-
inal girth and vertebral column length were the key
determinants of 0.5 % plain bupivacaine volume (both
p < 0.0001), while age, weight, and height could be
omitted without changing the results (all p > 0.164, all
95 % confidence intervals < 0.267) (Table 3). R2 was
0.874 for the loss of pinprick discrimination at T12 and
0.860 for the loss of pinprick discrimination at T10.
The regression equations between the 0.5 % plain
bupivacaine volume and vertebral column length,
abdominal girth for loss of pinprick discrimination at
T12 and at T10 were YT12 = 3.547 + 0.045X1-0.044X2 and
YT10 = 3.848 + 0.047X1- 0.046X2, respectively (Y, 0.5 %
plain bupivacaine volume; X1, vertebral column lengt-
h;and X2, abdominal girth).
Fig. 1 Consort flowchart for the intrathecal plain bupivacaine dose can be predicted by abdominal girth and vertebral column length
Table 1 Patient variables and bupivacaine doses
Loss of pinprick
discrimination
at T12(n = 111)
Loss of pinprick
discrimination
at T10(n = 121)
ASA status (I/II) 82/29 95/26
Sex, male/female 71/40 83/38
Age, y 44.6 (11.7) 44.9 (11.9)
Height, cm 165.2(8.3) 165.9(7.3)
Weight, kg 64.3 (10.9) 67.9 (11.3)
Vertebral column length, cm 65.2(4.9) 65.2(4.4)
Abdominal girth, cm 78.1(9.9) 81.5(8.8)
0.5 % plain bupivacaine volume, ml 3.04(0.51) 3.18(0.44)
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Discussion
The most important finding of the present study was
that vertebral column length and abdominal girth were
strongly correlated with the dosage of intrathecal plain
bupivacaine for the loss of pinprick discrimination at
T12 and T10. This finding indicated that the requirement
of intrathecal plain bupivacaine dose could be largely
predicted by vertebral column length and abdominal
girth for lower limb surgeries.
A previous study showed that the volume of lumbosa-
cral cerebrospinal fluid was the primary determinant of
sensory block level during spinal anesthesia [10], and
there was broad variation in the volume of lumbosacral
cerebrospinal fluid between individuals, which decreased
following an increase in intra-abdominal pressure [11].
Greater abdominal girth was associated with a more not-
able increase in the intra-abdominal pressure [17]. Logic
might suggest that there would be a smaller volume of
lumbosacral cerebrospinal fluid in patients with shorter
vertebral column lengths. Thus, to a great extent,
abdominal girth and vertebral column length could
accurately predict the dosage of intrathecal plain bupiva-
caine for T12 and T10 block level.
Many studies have investigated the effects of a patient’s
age [13], height [1, 12], weight and BMI [1, 12, 14] on
the spread of plain bupivacaine spinal anesthesia, but
the results have been contradictory, or the variables have
demonstrated to be weakly correlated with the spread of
spinal anesthesia. Using three-dimensional magnetic res-
onance imaging, Sullivan and his colleagues [18] further
proved that only weak correlations existed between the
volume of lumbosacral cerebrospinal fluid and height,
weight or BMI. In our previous and current studies,
multiple linear regression analysis also showed that
among the five predictors, age, weight and height had
low value for predicting the dosage of intrathecal bupi-
vacaine for the level of anticipant spinal anesthesia.
To date, some studies have been performed to investi-
gate the optimal dose of intrathecal plain bupivacaine
for certain surgeries [5, 19]. However, these studies have
only demonstrated the range of the intrathecal bupiva-
caine (e.g., ED50 or ED95) but not the optimal individual
Table 2 The relationship of patient variables with the bupivacaine dose for loss of pinprick discrimination at T12 and T10
Patient characteristics 0.5 % plain bupivacaine volume for loss of pinprick
discrimination at T12
0.5 % plain bupivacaine volume for loss of
pinprick discrimination at T10
r p value r p value
Age −0.335 <0.001 −0.362 <0.001
Height 0.367 <0.001 0.195 0.0324
Weight −0.494 <0.001 −0.460 <0.001
Vertebral column length 0.383 <0.001 0.203 0.0257
Abdominal girth −0.827 <0.001 −0.806 <0.001
r: correlation coefficient
Fig. 2 Linear regression analysis of abdominal girth and 0.5 % plain
bupivacaine volume for loss of pinprick discrimination at T12. r = -0.827,
p < 0.0001. r: correlation coefficient
Fig. 3 Linear regression analysis of abdominal girth and 0.5 % plain
bupivacaine volume for loss of pinprick discrimination at T10. r = -0.806,
p < 0.0001. r: correlation coefficient
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dose.5 Indeed, the ED50 or ED95 values could provide
some guidance for using local anesthetics, but even if
low doses of intrathecal plain bupivacaine were used,
hypotension could still occurred because of excessive
cephalad spread [19].
In previous studies, up-down sequential analysis [20]
and logistic regression analyses [5] have been used to de-
termine the optional dose of local anesthetics. Neither
method could determine the optimal dose for an individ-
ual because the individual response to intrathecal local
anesthesia varies greatly. In the current study, multiple
linear regression analysis was performed to investigate
the combined linear contribution of five patient variables
to the volume of 0.5 % plain bupivacaine for loss of pin-
prick discrimination at T12 and T10, then the regression
equations between the 0.5 % plain bupivacaine volume
and vertebral column length, abdominal girth were
obtained. The R2 for loss of pinprick discrimination at
both T12 and T10 was approximately 0.9, indicating that
the regression equation could accurately predict the dos-
age of specific intrathecal bupivacaine for T12 or T10
spinal spread in an individual.
In this study, reverse thoughts were used. We set T10
spinal block level as the target level, and the bupivacaine
dose administered was based on the experience of the
anesthetist. No matter how much the bupivacaine dose
were used, there were many possibilities that some
patients, spinal upper block level would be T12 or T10.
When the sample size, based on spinal spread for loss of
pinprick discrimination at T12 and T10, reached 91
respectively could the study be terminated. Finally, 111
patients with loss of pinprick discrimination at T12 and
121 patients with loss of pinprick discrimination at T10
were enrolled in our study. 391 patients with loss of pin-
prick discrimination for other spinal levels were not
analyzed.
Reynolds F. [21] advised avoiding spinal injection above
L3 to decrease the risk of spinal cord trauma. Therefore,
the L3-L4 interspace is usually the targeted intervertebral
needle insertion site during spinal anesthesia, and it was
adopted in our study. The accuracy of the regression
equation for the dosage of intrathecal bupivacaine and
vertebral column length and abdominal girth for T10 and
T12 spinal spread levels should be confirmed in the future
with larger samples. The subjects of this study were 19 to
60 years old; therefore, the accuracy of the regression
equation for patients of other ages should also be
confirmed.
Conclusion
In conclusion, our data indicated that vertebral column
length and abdominal girth were strongly correlated with
the dosage of intrathecal plain bupivacaine for the loss of
pinprick discrimination at T12 and T10. The two regression
equations were YT12 = 3.547 + 0.045X1-0.044X2 and
YT10 = 3.848 + 0.047X1- 0.046X2 (Y, 0.5 % plain bupi-
vacaine volume; X1, vertebral column length;and X2,
abdominal girth), which can accurately predict the
minimum and suitable intrathecal bupivacaine dose
for lower limb surgeries to a great extent separately.
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Table 3 The combined linear regression of patient variables with bupivacaine dose for loss of pinprick discrimination at T12 and T10
Patient characteristics 0.5 % plain bupivacaine volume for loss of pinprick
discrimination at T12
0.5 % plain bupivacaine volume for loss of pinprick
discrimination at T10
b p value 95 % CI b p value 95 % CI
lower limit upper limit lower limit upper limit
Age 0.016 0.667 −0.140 0.226 0.027 0.725 −0.100 0.232
Height 0.020 0.717 −0.122 0.267 0.084 0.164 −0.098 0.245
Weight −0.062 0.422 −0.331 0.107 0.090 0.200 −0.119 0.231
Abdominal girth −0.044 <0.001 −0.777 −0.563 −0.046 <0.001 −0.861 −0.713
Vertebral column length 0.045 <0.001 0.431 0.726 0.047 <0.001 0.399 0.648
b: regression coefficient; 95 % CI: 95 % confidence interval for the partial correlation coefficients
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